Causes and Risks:
The cause of the disease is unknown. Tissue samples from involved organs show granulomas, which are clusters of macrophages, lymphocytes, and cells called multinucleated giant cells. Possible causes include a hypersensitivity response, a genetic predisposition, infection, or chemicals. The incidence varies widely according to race and sex. Incidence is highest among North Americans of African heritage and Northern European Caucasians. Women of African heritage are affected more than men of African heritage. The onset of the disease usually occurs in people between 30 and 50 years old. Sarcoidosis is very rare in young children.
Symptoms:
Additional symptoms that may be associated with this disease:
Note: There may be no symptoms.
Signs and Tests:
This disease may also alter the results of the following tests:
Treatment:
Sarcoidosis symptoms often gradually resolve on their own without treatment. Individuals who are more severely affected require treatment with corticosteroids. Therapy may continue for 1 or 2 years, although some affected may require life-long therapy. Other drugs sometimes used in addition to corticosteroids are immunosuppressive agents such as methotrexate, azathioprine, and cyclophosphamide. Rarely some individuals with irreversible organ failure require organ transplantation.
Prognosis:
Many people are not seriously ill, and the disease may resolve without treatment. Thirty to fifty percent of cases resolve without treatment in 3 years. About 20% of those with lung involvement will develop residual lung damage. Death from sarcoidosis is very rare in the first several years with the disease and remains uncommon thereafter.
Complications:
Call your health care provider if difficulty breathing, vision changes, palpitations, or other symptoms develop.